Finasteride contains not less than 98.0% and not more than 102.0% of C23H36N2O2, calculated on the anhydrous basis.

共有 1 個藥物證書使用此成份

菲斯坦
Finasteride

• 申請商: 丞泰企業有限公司
• 適應症: 良性前列腺增生
• 發證日期: 2015-03-03